Medical Excellence Capital
Signal active
Investment Firm
Overview
Medical Excellence Capital is an early stage life sciences fund that combines a unique global network of physician scientists with a team of experienced investors, company builders, and operators.
Highlights
Founded
2020
Industry
Employees
1-10
Investment
8
Lead Investment
3
Exits
undefined
Stages
Seed, Early Stage Venture
Investor Type
Venture Capital
Location
New York, New York, United States, North America
Contact Information
Social
Profile Resume
Medical Excellence Capital, established in 2020 and headquartered in New York, New York, United States, North America., specializes in Seed, Early Stage Venture investments across Biotechnology, Life Science, Health Care, Medical Device, Health Diagnostics, Financial Services, Venture Capital, Finance, Education, mHealth. Their recent investments include Truvian Sciences, GreatPoint Ventures, 7wire Ventures, DNS Capital, Tao Capital Partners. The highest investment round they participated in was $52.1B. Among their most notable exits are Truvian Sciences and GreatPoint Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
Medical Excellence Capital has made 8 investments. Their most recent investment was on Feb 16, 2023, when Avilar Therapeutics raised $15.0M.
Medical Excellence Capital has made 4 diversity investments. Their most recent diversity investment was on Jul 17, 2024, when Truvian Sciences raised $74.0M.
investments
8
Diversity investments
4
Lead investments
3
Number of exits
undefined
Investments
8
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Dec 05, 2022 | SonoThera | Biotechnology | 60.8M |
| Feb 16, 2023 | Avilar Therapeutics | Biotechnology | 15.0M |
| Nov 02, 2023 | ProJenX | Biotechnology | 15.0M |
| Jul 17, 2024 | Truvian Sciences | Biotechnology | 74.0M |
Exits
0
Funding Timeline
Funding rounds
8
Investors
0
Funds
1
Funding Rounds
8
Medical Excellence Capital has raised 8 rounds. Their latest funding was raised on Jul 17, 2024 from a Venture Round - Truvian Sciences round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Dec 05, 2022 | Series A - SonoThera | - | 60.8M | - |
| Feb 16, 2023 | Seed Round - Avilar Therapeutics | - | 15.0M | - |
| Nov 02, 2023 | Series A - ProJenX | - | 15.0M | - |
| Jul 17, 2024 | Venture Round - Truvian Sciences | - | 74.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.